Cerity Partners LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1566475 NEW YORK, NY

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$754,983

-$394,832 QoQ

Shares Held

80,147

+20.2% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 7.033326262991753.ToString("F0")% Shared 17.013737257788815.ToString("F0")% None 75.95293647921943.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $355,132,750 across 115 Biotechnology names. FTRE ranks #34 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	296,654	$132,467,876
2	REGN	Regeneron Pharmaceuticals, Inc.	43,972	$33,974,525
3	CORT	Corcept Therapeutics Inc	731,689	$29,494,383
4	HALO	Halozyme Therapeutics, Inc.	349,137	$22,564,723
5	INCY	Incyte Corp	226,501	$21,318,272
6	BMRN	Biomarin Pharmaceutical Inc	263,389	$14,878,843
7	EXEL	Exelixis, Inc.	313,945	$13,465,100
8	JAZZ	Jazz Pharmaceuticals plc	45,746	$8,648,280

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$754,983	80,147	+20.2%	Shares	Defined	2026-05-15
2025-12-31	$1,149,815	66,656	+4.6%	Shares	Sole	2026-02-11
2025-09-30	$536,421	63,708	-14.1%	Shares	Sole	2025-10-22
2025-06-30	$366,350	74,160	+156.0%	Shares	Sole	2025-08-13
2025-03-31	$218,731	28,971	+93.3%	Shares	Sole	2025-04-30
2024-12-31	$279,526	14,988	-1.0%	Shares	Defined	2025-02-13
2024-09-30	$302,860	15,143	+8.1%	Shares	Defined	2024-11-12
2024-06-30	$326,806	14,002	-12.4%	Shares	Sole	2024-08-13
2024-03-31	$641,918	15,992	+22.6%	Shares	Defined	2024-05-14
2023-12-31	$455,061	13,039	+31.9%	Shares	Sole	2024-01-26
2023-09-30	$282,583	9,884	-70.1%	Shares	Sole	2023-11-14
2023-06-30	$1,124,370	33,060	—	Shares	Other	2023-08-14
No filing history on record for this holder in this stock.